Home › Funds › PNC Financial Services › STRO
PNC Financial Services position in STRO
SUTRO BIOPHARMA INC · Health Care
Latest position (Q2 2026)62 sh
Reported value held$2.06K
Portfolio Weight0.00%
First reportedQ2 2024
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2024 | 51 | $149 | New |
| Q3 2024 | 51 | $176 | Hold |
| Q4 2024 | 51 | $94 | Hold |
| Q1 2025 | 666 | $434 | Add |
| Q2 2025 | 769 | $549 | Add |
| Q3 2025 | 614 | $533 | Reduce |
| Q4 2025 | 62 | $717 | Reduce |
| Q1 2026 | 62 | $1.54K | Hold |
| Q2 2026 | 62 | $2.06K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding STRO
- BlackRock Inc 1.12M sh · $37.27M · Q2 2026
- Balyasny Asset Management 711.16K sh · $23.61M · Q2 2026
- Geode Capital Management 389.69K sh · $12.94M · Q2 2026
- Millennium Management 365.97K sh · $12.15M · Q2 2026
- Point72 Asset Management 237.83K sh · $7.90M · Q2 2026
- UBS Group AG 208.51K sh · $6.92M · Q2 2026
- Two Sigma Investments 201.69K sh · $6.70M · Q2 2026
- Marshall Wace 175.25K sh · $5.82M · Q2 2026
- JPMorgan Chase & Co 159.63K sh · $5.32M · Q2 2026
- Goldman Sachs Group 149.22K sh · $4.95M · Q2 2026
- Vanguard Group 375.79K sh · $4.35M · Q4 2025
- Northern Trust Corp 125.93K sh · $4.18M · Q2 2026